Devices | bioequivalence.eu

Devices

Drug Delivery to the Lungs (Ref 3) Differences between inhalation devices can cause several fold changes in efficacy as well as systemic bioavailability. Therefore, if a pMDI is to be used in children it must be developed for use together with a specific appropriate spacing device.
bioequivalence.eu
Professor Hans Bisgaard • Copenhagen • Denmark • Bisgaard@copsac.com